Literature DB >> 9397986

Modulation of liver canalicular transport processes by the tyrosine-kinase inhibitor genistein: implications of genistein metabolism in the rat.

W Jäger1, O Winter, B Halper, A Salamon, M Sartori, L Gajdzik, G Hamilton, G Theyer, J Graf, T Thalhammer.   

Abstract

Rat liver cells express the multispecific organic anion transporter (cmoat, cmrp, mrp2) and P-glycoprotein (Pgp) in their canalicular membranes, proteins that are homologous to the multidrug-resistance related protein (MRP) and multidrug resistance (MDR) gene products in multidrug resistant tumor cells. We tested whether genistein, a modulator of drug resistance in tumor cells, affects biliary secretion of substrates of canalicular multispecific organic anion transporter (cmoat) (glucuronides of bilirubin and rhodamine, glutathione conjugate of bromsulphthalein) and of P-glycoprotein (Pgp) (rhodamine), respectively. Using the isolated perfused rat liver of control Wistar rats (TR+) and of a mutant strain (TR-) that expresses Pgp but not cmoat, we show that genistein effectively inhibits the secretion of anionic substrates of cmoat in Wistar rats but stimulates secretion of cationic rhodamine in TR- rats. Genistein is subject to glucuronidation and sulfatation and secretion of genistein and its metabolites stimulates bile flow in Wistar rats, but secretion is nearly absent in TR- rats. Because genistein and its metabolites are substrates for cmoat, inhibition of anion secretion by genistein is partially explained by competition for this transporter. Genistein is also a substrate of uridindiphosphate (UDP)-glucuronyltransferase isoenzyme(s). Inhibition of glucuronidation reduces the availability of bilirubin and rhodamine glucuronates for transport via cmoat, but unconjugated cationic rhodamine becomes available for transport via Pgp at an increased cellular concentration. Daidzein, a genistein analogue with no effect on protein tyrosine kinase (PTK) shows Similar effects on secretion of organic anions and cations supporting the conclusion that genistein affects transport in liver mainly through competition with other substrates at the sites of glucuronidation and transport via cmoat.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9397986     DOI: 10.1002/hep.510260613

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  12 in total

1.  Glyceollin Effects on MRP2 and BCRP in Caco-2 Cells, and Implications for Metabolic and Transport Interactions.

Authors:  Chukwuemezie Chimezie; Adina Ewing; Chandler Schexnayder; Melyssa Bratton; Elena Glotser; Elena Skripnikova; Pedro Sá; Stephen Boué; Robert E Stratford
Journal:  J Pharm Sci       Date:  2016-01-11       Impact factor: 3.534

Review 2.  Effects of food on the clinical pharmacokinetics of anticancer agents: underlying mechanisms and implications for oral chemotherapy.

Authors:  Brahma N Singh; Bimal K Malhotra
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 3.  Interplay of drug metabolizing enzymes with cellular transporters.

Authors:  Michaela Böhmdorfer; Alexandra Maier-Salamon; Juliane Riha; Stefan Brenner; Martina Höferl; Walter Jäger
Journal:  Wien Med Wochenschr       Date:  2014-09-10

Review 4.  Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosis.

Authors:  C R Sirtori
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

5.  Increased transport of resveratrol across monolayers of the human intestinal Caco-2 cells is mediated by inhibition and saturation of metabolites.

Authors:  Alexandra Maier-Salamon; Birgit Hagenauer; Michael Wirth; Franz Gabor; Thomas Szekeres; Walter Jäger
Journal:  Pharm Res       Date:  2006-08-09       Impact factor: 4.200

Review 6.  Application of Caco-2 cell line in herb-drug interaction studies: current approaches and challenges.

Authors:  Charles Awortwe; P S Fasinu; B Rosenkranz
Journal:  J Pharm Pharm Sci       Date:  2014       Impact factor: 2.327

7.  Cellular Pharmacokinetic Model-Based Analysis of Genistein, Glyceollin, and MK-571 Effects on 5 (and 6)-Carboxy-2',7'-Dichloroflourescein Disposition in Caco-2 Cells.

Authors:  Callie Drennen; Erin Gorse; Robert E Stratford
Journal:  J Pharm Sci       Date:  2017-12-14       Impact factor: 3.534

8.  Structure-activity relationship of halophenols as a new class of protein tyrosine kinase inhibitors.

Authors:  Xiu E Feng; Wan Yi Zhao; Shu Rong Ban; Cheng Xiao Zhao; Qing Shan Li; Wen Han Lin
Journal:  Int J Mol Sci       Date:  2011-09-19       Impact factor: 5.923

9.  Characterization of rhodamine-123 as a tracer dye for use in in vitro drug transport assays.

Authors:  Samantha Forster; Alfred E Thumser; Steve R Hood; Nick Plant
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

10.  Genistein and Glyceollin Effects on ABCC2 (MRP2) and ABCG2 (BCRP) in Caco-2 Cells.

Authors:  Chandler Schexnayder; Robert E Stratford
Journal:  Int J Environ Res Public Health       Date:  2015-12-22       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.